Hepatocyte nuclear factor-1 alpha gene mutations and diabetes in Norway.
Bjørkhaug L, Sagen JV, Thorsby P, Søvik O, Molven A, Njølstad PR.
J Clin Endocrinol Metab. 2003 Feb;88(2):920-31. doi: 10.1210/jc.2002-020945.
Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young.
Bulman MP, Harries LW, Hansen T, Shepherd M, Kelly WF, Hattersley AT, Ellard S.
Diabetologia. 2002 Oct;45(10):1463-7. doi: 10.1007/s00125-002-0919-1. Epub 2002 Sep 11.
Characterization of a naturally occurring mutation (L107I) in the HNF1 alpha (MODY3) gene.
Cervin C, Orho-Melander M, Ridderstråle M, Lehto M, Barg S, Groop L, Cilio CM.
Diabetologia. 2002 Dec;45(12):1703-8. doi: 10.1007/s00125-002-0977-4. Epub 2002 Oct 19.
Monogenic diabetes mellitus in youth. The MODY syndromes.
Winter WE, Nakamura M, House DV.
Endocrinol Metab Clin North Am. 1999 Dec;28(4):765-85. doi: 10.1016/s0889-8529(05)70101-8.
HNF1 alpha gene coding regions mutations screening, in a Caucasian population clinically characterized as MODY from Argentina.
Lopez AP, Foscaldi SA, Perez MS, Rodriguez M, Traversa M, Puchulu FM, Bergada I, Frechtel GD.
Diabetes Res Clin Pract. 2011 Feb;91(2):208-12. doi: 10.1016/j.diabres.2010.11.024. Epub 2010 Dec 17.
[Maturity-onset diabetes of the young--MODY. Molecular-genetic, pathophysiological and clinical characteristics].
Hansen T, Urhammer SA, Pedersen OB.
Ugeskr Laeger. 2002 Apr 8;164(15):2017-22.
Promoter-specific repression of hepatocyte nuclear factor (HNF)-1 beta and HNF-1 alpha transcriptional activity by an HNF-1 beta missense mutant associated with Type 5 maturity-onset diabetes of the young with hepatic and biliary manifestations.
Kitanaka S, Miki Y, Hayashi Y, Igarashi T.
J Clin Endocrinol Metab. 2004 Mar;89(3):1369-78. doi: 10.1210/jc.2003-031308.
[Childhood-onset diabetes treated with sulphonylureas].
Palomo Atance E, Ballester Herrera MJ, Giralt Muiña P, López Garrido P.
An Pediatr (Barc). 2008 Dec;69(6):568-71. doi: 10.1016/s1695-4033(08)75241-x.
